367 related articles for article (PubMed ID: 8356789)
61. Inhibition of HIV-1 gene expression by novel macrophage-tropic DNA enzymes targeted to cleave HIV-1 TAT/Rev RNA.
Unwalla H; Banerjea AC
Biochem J; 2001 Jul; 357(Pt 1):147-55. PubMed ID: 11415445
[TBL] [Abstract][Full Text] [Related]
62. HIV-1 gp120/160 expressing cells upregulate HIV-1 LTR directed gene expression in a cell line transfected with HIV-1 LTR-reporter gene constructs.
Merzouki A; Patel P; Cassol S; Ennaji M; Tailor P; Turcotte FR; O'Shaughnessy M; Arella M
Cell Mol Biol (Noisy-le-grand); 1995 May; 41(3):445-52. PubMed ID: 7580840
[TBL] [Abstract][Full Text] [Related]
63. The HIV-1 transactivator protein Tat is a potent inducer of the human DNA repair enzyme beta-polymerase.
Srivastava DK; Tendler CL; Milani D; English MA; Licht JD; Wilson SH
AIDS; 2001 Mar; 15(4):433-40. PubMed ID: 11242139
[TBL] [Abstract][Full Text] [Related]
64. A bidirectional SF2/ASF- and SRp40-dependent splicing enhancer regulates human immunodeficiency virus type 1 rev, env, vpu, and nef gene expression.
Caputi M; Freund M; Kammler S; Asang C; Schaal H
J Virol; 2004 Jun; 78(12):6517-26. PubMed ID: 15163745
[TBL] [Abstract][Full Text] [Related]
65. Efficiency of reinitiation of translation on human immunodeficiency virus type 1 mRNAs is determined by the length of the upstream open reading frame and by intercistronic distance.
Luukkonen BG; Tan W; Schwartz S
J Virol; 1995 Jul; 69(7):4086-94. PubMed ID: 7769666
[TBL] [Abstract][Full Text] [Related]
66. Persistence of attenuated rev genes in a human immunodeficiency virus type 1-infected asymptomatic individual.
Iversen AK; Shpaer EG; Rodrigo AG; Hirsch MS; Walker BD; Sheppard HW; Merigan TC; Mullins JI
J Virol; 1995 Sep; 69(9):5743-53. PubMed ID: 7637019
[TBL] [Abstract][Full Text] [Related]
67. Mutational inactivation of an inhibitory sequence in human immunodeficiency virus type 1 results in Rev-independent gag expression.
Schwartz S; Campbell M; Nasioulas G; Harrison J; Felber BK; Pavlakis GN
J Virol; 1992 Dec; 66(12):7176-82. PubMed ID: 1433510
[TBL] [Abstract][Full Text] [Related]
68. Rev-dependent expression of three species of HIV-1 mRNAs (review).
Fukumori T; Kagawa S; Iida S; Oshima Y; Akari H; Koyama AH; Adachi A
Int J Mol Med; 1999 Mar; 3(3):297-302. PubMed ID: 10028055
[TBL] [Abstract][Full Text] [Related]
69. Expression kinetics and subcellular localization of HIV-1 regulatory proteins Nef, Tat and Rev in acutely and chronically infected lymphoid cell lines.
Ranki A; Lagerstedt A; Ovod V; Aavik E; Krohn KJ
Arch Virol; 1994; 139(3-4):365-78. PubMed ID: 7832642
[TBL] [Abstract][Full Text] [Related]
70. Study of the HIV-2 Env cytoplasmic tail variability and its impact on Tat, Rev and Nef.
Bakouche N; Vandenbroucke AT; Goubau P; Ruelle J
PLoS One; 2013; 8(11):e79129. PubMed ID: 24223892
[TBL] [Abstract][Full Text] [Related]
71. The Effect of a Single Nucleotide Substitution in the Splicing Silencer in the tat/rev Intron on HIV Type 1 Envelope Expression.
Paca-Uccaralertkun S; Damgaard CK; Auewarakul P; Thitithanyanont A; Suphaphiphat P; Essex M; Kjems J; Lee TH
AIDS Res Hum Retroviruses; 2006 Jan; 22(1):76-82. PubMed ID: 16438649
[TBL] [Abstract][Full Text] [Related]
72. A Janus splicing regulatory element modulates HIV-1 tat and rev mRNA production by coordination of hnRNP A1 cooperative binding.
Marchand V; Méreau A; Jacquenet S; Thomas D; Mougin A; Gattoni R; Stévenin J; Branlant C
J Mol Biol; 2002 Nov; 323(4):629-52. PubMed ID: 12419255
[TBL] [Abstract][Full Text] [Related]
73. Activation of a diphtheria toxin A gene by expression of human immunodeficiency virus-1 Tat and Rev proteins in transfected cells.
Harrison GS; Maxwell F; Long CJ; Rosen CA; Glode LM; Maxwell IH
Hum Gene Ther; 1991; 2(1):53-60. PubMed ID: 1863640
[TBL] [Abstract][Full Text] [Related]
74. A naturally arising mutation of a potential silencer of exon splicing in human immunodeficiency virus type 1 induces dominant aberrant splicing and arrests virus production.
Wentz MP; Moore BE; Cloyd MW; Berget SM; Donehower LA
J Virol; 1997 Nov; 71(11):8542-51. PubMed ID: 9343212
[TBL] [Abstract][Full Text] [Related]
75. Novel mono- and di-DNA-enzymes targeted to cleave TAT or TAT-REV RNA inhibit HIV-1 gene expression.
Unwalla H; Banerjea AC
Antiviral Res; 2001 Aug; 51(2):127-39. PubMed ID: 11431037
[TBL] [Abstract][Full Text] [Related]
76. The development and testing of retroviral vectors expressing trans-dominant mutants of HIV-1 proteins to confer anti-HIV-1 resistance.
Liem SE; Ramezani A; Li X; Joshi S
Hum Gene Ther; 1993 Oct; 4(5):625-34. PubMed ID: 8280800
[TBL] [Abstract][Full Text] [Related]
77. Cloning and characterization of cDNAs encoding equine infectious anemia virus tat and putative Rev proteins.
Stephens RM; Derse D; Rice NR
J Virol; 1990 Aug; 64(8):3716-25. PubMed ID: 2164593
[TBL] [Abstract][Full Text] [Related]
78. Elements distinct from human immunodeficiency virus type 1 splice sites are responsible for the Rev dependence of env mRNA.
Nasioulas G; Zolotukhin AS; Tabernero C; Solomin L; Cunningham CP; Pavlakis GN; Felber BK
J Virol; 1994 May; 68(5):2986-93. PubMed ID: 8151769
[TBL] [Abstract][Full Text] [Related]
79. Human immunodeficiency virus env expression becomes Rev-independent if the env region is not defined as an intron.
Hammarskjöld ML; Li H; Rekosh D; Prasad S
J Virol; 1994 Feb; 68(2):951-8. PubMed ID: 8289397
[TBL] [Abstract][Full Text] [Related]
80. U1 small nuclear RNA plays a direct role in the formation of a rev-regulated human immunodeficiency virus env mRNA that remains unspliced.
Lu XB; Heimer J; Rekosh D; Hammarskjöld ML
Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7598-602. PubMed ID: 2217190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
